Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya
- PMID: 20487430
- PMCID: PMC2929358
- DOI: 10.1111/j.1365-3156.2010.02539.x
Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya
Abstract
Background: To describe incidence rates (IR) and risk factors for loss-to-follow-up (LTFU) among HIV-infected and HIV-exposed children in a large HIV treatment programme in Western Kenya.
Methods: The USAID-AMPATH Partnership has enrolled >100,000 patients (20% children) at 23 clinic sites throughout western Kenya. LTFU is defined as being absent from the clinic for >3 months if on combination antiretroviral treatment (cART) and >6 months if not. Included in this analysis were children aged <14 years, HIV exposed or infected at enrollment, and enrolled between April 2002 and March 2009. The IR for LTFU are presented per 100 child-years (CY) of follow-up. Proportional hazards models with time-independent and time-dependent covariates were used to model factors associated with LTFU. Weight for height Z-scores were calculated using EpiInfo, with severe malnutrition being defined as a Z-score <or=-3.0. Immune suppression was defined as per WHO age-specific categories.
Results: There were 13,510 children eligible for analysis, comprising 3106 children who at enrollment were HIV infected and 10,404 children who were HIV exposed. The overall IR of LTFU was 18.4 (17.8-18.9) per 100 CY. Among HIV-infected children, 15.2 (13.8-16.7) and 14.1 (13.1-15.8) per 100 CY became LTFU, pre- and post-cART initiation, respectively. The only independent risk factor for becoming LTFU among the HIV-infected children was severe immune suppression (AHR: 2.17, 95% CI: 1.51-3.12). Among the HIV-exposed children, 20.1 per 100 (19.4-20.7) became LTFU. Independent risk factors for LTFU among them were being severely low weight for height (AHR: 1.69, 95% CI: 1.25-2.28), being orphaned at enrollment (AHR: 1.57, 95% CI: 1.23-1.64), being CDC Class B or C (AHR: 1.41, 95% CI: 1.14-1.74), and having received cART (AHR: 1.56, 95% CI: 1.23-1.99). Protective against becoming LTFU among the HIV exposed were testing HIV positive (AHR: 0.26, 95% CI: 0.21-0.32), older age (AHR: 0.90, 95% CI: 0.85-0.96), enrolling in later time periods, and receiving food supplementation (AHR: 0.58, 95% CI: 0.32-1.04).
Conclusions: There is a high rate of LTFU among these highly vulnerable children, particularly among the HIV exposed. These data suggest that HIV-infected and HIV-exposed children are at especially high risk for LTFU if they are sick or malnourished.
Figures
Similar articles
-
The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5. Pediatr Infect Dis J. 2009. PMID: 19451858
-
Characteristics of HIV-infected children seen in Western Kenya.East Afr Med J. 2009 Aug;86(8):364-73. doi: 10.4314/eamj.v86i8.54156. East Afr Med J. 2009. PMID: 20575310
-
Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.AIDS Care. 2016;28(4):500-7. doi: 10.1080/09540121.2015.1110234. Epub 2015 Nov 12. AIDS Care. 2016. PMID: 26565428 Free PMC article.
-
Community-based supplementary feeding for food insecure, vulnerable and malnourished populations - an overview of systematic reviews.Cochrane Database Syst Rev. 2018 Nov 9;11(11):CD010578. doi: 10.1002/14651858.CD010578.pub2. Cochrane Database Syst Rev. 2018. PMID: 30480324 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.Medicine (Baltimore). 2018 Jul;97(29):e10901. doi: 10.1097/MD.0000000000010901. Medicine (Baltimore). 2018. PMID: 30024494 Free PMC article.
-
Implementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e73-83. doi: 10.1097/QAI.0000000000000782. J Acquir Immune Defic Syndr. 2015. PMID: 26247894 Free PMC article.
-
Psychometric Assessment of a Physician-Patient Communication Behaviors Scale: The Perspective of Adult HIV Patients in Kenya.AIDS Res Treat. 2013;2013:706191. doi: 10.1155/2013/706191. Epub 2013 Feb 11. AIDS Res Treat. 2013. PMID: 23476754 Free PMC article.
-
Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.Curr HIV Res. 2015;13(3):201-9. doi: 10.2174/1570162x1303150506183256. Curr HIV Res. 2015. PMID: 25986371 Free PMC article.
-
Asking the right questions: developing evidence-based strategies for treating HIV in women and children.BMC Public Health. 2011 May 25;11:388. doi: 10.1186/1471-2458-11-388. BMC Public Health. 2011. PMID: 21612633 Free PMC article.
References
-
- Moatti JP, I ND, Hammer SM, et al. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm. Nature Medicine. 2003;9(12):1449–1452. - PubMed
-
- World Health Organization . In: Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. W.H. Organization, editor. World Health Organization; Geneva: 2008.
-
- UNAIDS . Report on the Global AIDS Epidemic. Joint United Nations Program on HIV/AIDS; Geneva: 2008.
-
- Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49(5):523–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous